Early-stage cancer treatment, driven by context of molecular imaging (ESTIMA)

Description

The primary goal of this prospective observational project proposed by INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL, EPE is to determine the personalized patient pharmacogenetic profile to evaluate the effectiveness of the current treatment (neoadjuvant radio/chemotherapy followed by surgery) approach for oesophagic early-stage cancers. The project aims to determine a clear definition of the criteria for non- surgical (conservative) approach of these patients.

Researchers

Funded by

Project NORTE-01-0145-FEDER-000027, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)

Partners

INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL EPE (Instituição proponente)

Keywords

Oesophagic cancer; Precision Medicine; Pattern Recognition; Machine learning; Image processing;

Start Date

2016-03-01

End Date

2019-03-31